May 22, 2020 / 12:18 PM / 13 days ago

BRIEF-Intercept Pharmaceuticals Provides Regulatory Update

May 22 (Reuters) - Intercept Pharmaceuticals Inc:

* INTERCEPT PROVIDES REGULATORY UPDATE

* INTERCEPT PHARMACEUTICALS - FDA NOTIFIED THAT TENTATIVELY SCHEDULED JUNE 9, ADCOM RELATING TO NDA FOR OBETICHOLIC ACID (OCA) HAS BEEN POSTPONED

* INTERCEPT PHARMACEUTICALS - POSTPONEMENT TO ACCOMMODATE REVIEW OF ADDITIONAL DATA REQUESTED BY FDA THAT CO INTENDS TO SUBMIT WITHIN NEXT WEEK

* INTERCEPT PHARMACEUTICALS - FDA INDICATED IT WILL REACH OUT IN NEAR FUTURE WITH NEW PROPOSED ADCOM DATE

* INTERCEPT PHARMACEUTICALS - NOW ANTICIPATES THAT FDA’S REVIEW OF NDA WILL EXTEND BEYOND PDUFA TARGET ACTION DATE OF JUNE 26, 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below